What to do if your valsartan blood product is stopped by a health sale

The Medicines Agency announced today that it has blocked the sale of drugs containing valsartan due to the probable carcinogenic impurity of the active substance

The Component valsartan is part of high blood pressure, heart failure and the problem occurred when the manufacturing process of Zhejian Huahai Pharmaceuticals in China changed in 2012. It is not yet known whether is now available. impurities here potentially carcinogenic.

The institution clarified that all drugs containing valsartan are not stopped. These are only those containing the active substance valsartan provided by Zhejiang Huahai in the EU.

The Executive Agency for Medicines publishes a complete list of medicines whose sale is blocked. You can see the complete list of the website of the Agency. The institution has also published a list of drugs containing valsartan that, however, are not stopped.

There are many therapeutic alternatives to discontinued drugs on the market. These are drugs containing angiotensin II receptor antagonists. The BDA has published a list of these drugs, and they are divided into two groups depending on whether they are included in the list of positive or no drugs. The list can be found on the website of the institution.

Patients whose medicines for the blood and heart are on the list of blocked drugs should contact their GP to obtain a prescription for another drug, Dr. Nikolay Branzalov of the National Association of general practitioners in Bulgaria.

He stresses that patients must be calm because there is no need to worry

The Health Fund has announced that patients will be able to replace their drugs without haste with new drugs until 39th to 6th August.

Specialists advise patients not to stop taking valsartan-containing medications themselves if they are included with medications blocked by medications, but they must go to their GP to prescribe a new medication. drug.